CRI Worldwide, 1113 Hospital Dr. Suite 202, — Willingboro, New Jersey

CRI Worldwide, 1113 Hospital Dr. Suite 202, is a clinical research site located in Willingboro, New Jersey, United States 08046.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

CRI Worldwide, 1113 Hospital Dr. Suite 202, has participated in 1 clinical trials.

Therapeutic areas: Schizophrenia Disorders.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CRI Worldwide, 1113 Hospital Dr. Suite 202,?

CRI Worldwide, 1113 Hospital Dr. Suite 202, has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CRI Worldwide, 1113 Hospital Dr. Suite 202, conducted?

CRI Worldwide, 1113 Hospital Dr. Suite 202, has 1 clinical trials on record. Their work covers Schizophrenia Disorders.

Is CRI Worldwide, 1113 Hospital Dr. Suite 202, accredited by Crixeo Health?

CRI Worldwide, 1113 Hospital Dr. Suite 202, has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CRI Worldwide, 1113 Hospital Dr. Suite 202,?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.